Overcoming the Delivery Hurdle for Peptide Therapeutics: New Treatment for Autoimmune Diseases

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1042481

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Peptide blockers of a key potassium channel in T cells have been shown to be effective treatments for autoimmune diseases such as multiple sclerosis and rheumatoid arthritis. Our goal is to develop formulations of these peptides that will allow oral administration and thereby enhance their effectiveness as therapeutics.

Funded Activity Details

Start Date: 01-01-2013

End Date: 01-01-2015

Funding Scheme: Project Grants

Funding Amount: $574,955.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Biochemistry and Cell Biology not elsewhere classified

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

animal model | autoimmune disease | electrophysiology | encapsulation | lipids | peptides | potassium channels | transport

Related Links